Narayana Hrudayalaya runs a chain of multi-speciality hospitals located across India. The company also operates primary care facilities, heart centres, and other healthcare facilities. The company has its headquarters in Bengaluru. Narayana Health was started by Dr Devi Shetty in 2000. As on 19 December 2022, the company employs more than 11,000 professionals a year.
On 19 December 2022, the market capitalisation of the company was Rs 15,434.35 crore. It reported consolidated sales of Rs 746.55 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 539551 and the National Stock Exchange with the code NH.
The promoters of Narayana Health currently hold approximately 63.85% of the company. The foreign institutional investors’ investment in the company amounts to 14.16%. Various mutual funds hold around 13.43% of the company. The total public stake in the company is approximately 8.3%. The stake of the public has grown steadily over the past year (Since September 2021).
Dr Devi Prasad Shetty is the chairman of the company and a whole-time director, and Emmanuel Rupert is the CEO and managing director. Viren Prasad Shetty, Kiran Mazumdar Shaw, Arun Seth, Dinesh Krishnaswamy, and TS Bresenham are the other directors of the company. Deloitte, Haskins, & Sells LLP are the auditors of Narayana Health. As of December 2022, the company had around 20.4 crore shares outstanding.
On 19 December 2022, Narayana Health’s share price on NSE was Rs 754.2 and Rs 753.3 on BSE. The share price touched a 52-week high of Rs 810.5 and a 52-week low of Rs 545.1. Its three-month return to investors was 8.64%, while its one-year return was 32.54%. The company’s total operating income grew 12.3% quarter-on-quarter during the fourth quarter of FY22.
As of November 2022, Axis Small Cap Direct-G has invested Rs 501.1 crore in the company. Other prominent mutual funds with investments in Naryana include SBI Small Cap Direct-G, with an investment of Rs 266.8 crore, and Nippon India Pharma Direct-G, with an investment of Rs 221.4 crore in the company.
Some of Narayana's peers include Max Healthcare, Fortis Healthcare, and Krishna Institute of Medicine.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: firstname.lastname@example.org. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.